Literature DB >> 5448782

Phenytoin tolerance tests.

A J Handley.   

Abstract

Oral and intravenous phenytoin tolerance tests showed distinctive biphasic curves with a fall in plasma phenytoin to very low levels after an initial peak and a rise to a secondary peak one to four hours later. It is suggested that this pattern should be borne in mind when intravenous phenytoin is being used, as in the control of status epilepticus or cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5448782      PMCID: PMC1701146          DOI: 10.1136/bmj.3.5716.203

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  INTESTINAL DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED DIPHENYHYDANTOIN IN THE RAT.

Authors:  E L NOACH; H VANREES
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-07-01

2.  Determination of diphenylhydantoin and phenobarbital in small amounts of serum.

Authors:  O SVENSMARK; P KRISTENSEN
Journal:  J Lab Clin Med       Date:  1963-03

3.  Effects of sodium diphenylhydantoinate upon isolated small intestine of the rabbit.

Authors:  R DRUCKMAN; F J MOORE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

4.  Studies on the absorption, distribution, fate and excretion of 4-C14-labeled diphenylhydantoin.

Authors:  E L NOACH; D M WOODBURY; L S GOODMAN
Journal:  J Pharmacol Exp Ther       Date:  1958-03       Impact factor: 4.030

5.  Studies on 5, 5'-diphenylhydantoin (dilantin) in animals and man.

Authors:  W A DILL; A J GLAZKO; A KAZENKO; L M WOLF
Journal:  J Pharmacol Exp Ther       Date:  1956-11       Impact factor: 4.030

6.  Relationship between the plasma level of diphenylhydantoin sodium and its cardiac antiarrhythmic effects.

Authors:  J T Bigger; D H Schmidt; H Kutt
Journal:  Circulation       Date:  1968-08       Impact factor: 29.690

7.  Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.

Authors:  A J Glazko; T Chang; J Baukema; W A Dill; J R Goulet; R A Buchanan
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

  7 in total
  3 in total

1.  Studies in man of phenytoin absorption and its implications.

Authors:  F B Gibberd; M Webley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

Review 2.  Cardiovascular adverse effects of phenytoin.

Authors:  B Guldiken; J Rémi; Soheyl Noachtar
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

3.  Enteric reabsorption processes and their impact on drug pharmacokinetics.

Authors:  Manuel Ibarra; Iñaki F Trocóniz; Pietro Fagiolino
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.